DK1226176T3 - Produktion af brystsekret-antistoffer i landbrugsdyr - Google Patents

Produktion af brystsekret-antistoffer i landbrugsdyr

Info

Publication number
DK1226176T3
DK1226176T3 DK00980089T DK00980089T DK1226176T3 DK 1226176 T3 DK1226176 T3 DK 1226176T3 DK 00980089 T DK00980089 T DK 00980089T DK 00980089 T DK00980089 T DK 00980089T DK 1226176 T3 DK1226176 T3 DK 1226176T3
Authority
DK
Denmark
Prior art keywords
breast
production
animal
compositions
agricultural animals
Prior art date
Application number
DK00980089T
Other languages
English (en)
Inventor
Sang He Lee
Original Assignee
Mucovax Holding B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mucovax Holding B V filed Critical Mucovax Holding B V
Application granted granted Critical
Publication of DK1226176T3 publication Critical patent/DK1226176T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK00980089T 1999-11-01 2000-10-31 Produktion af brystsekret-antistoffer i landbrugsdyr DK1226176T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16275299P 1999-11-01 1999-11-01
EP00202709 2000-07-27

Publications (1)

Publication Number Publication Date
DK1226176T3 true DK1226176T3 (da) 2006-06-06

Family

ID=26072559

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00980089T DK1226176T3 (da) 1999-11-01 2000-10-31 Produktion af brystsekret-antistoffer i landbrugsdyr

Country Status (14)

Country Link
EP (1) EP1226176B1 (da)
JP (1) JP4668499B2 (da)
KR (1) KR100627635B1 (da)
AT (1) ATE317400T1 (da)
AU (1) AU779776B2 (da)
CA (1) CA2389582C (da)
CY (1) CY1105024T1 (da)
DE (1) DE60025945T2 (da)
DK (1) DK1226176T3 (da)
ES (1) ES2258483T3 (da)
HK (1) HK1048323B (da)
NZ (1) NZ518638A (da)
PT (1) PT1226176E (da)
WO (1) WO2001032713A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2583061C (en) * 2004-10-06 2015-02-17 Kwang Guan Tay Antibody production method
AU2005291856B2 (en) * 2004-10-06 2011-05-12 Agri-Biotech Pty Ltd Antibody production method
CA2582487A1 (en) * 2004-10-06 2006-04-13 Agri-Biotech Pty Ltd. Milk production method
KR20100126760A (ko) 2008-02-28 2010-12-02 쓰리엠 이노베이티브 프로퍼티즈 캄파니 클로스트리듐 디피실레 포자에 대한 항체 및 그 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201698A (en) * 1981-08-31 1985-12-13 S L Gaffin Composition of antibodies specific to endotoxins
US4944942A (en) * 1987-08-27 1990-07-31 Mobay Corporation Intranasal vaccination of horses with inactivated microorganisms or antigenic material
JPH0892108A (ja) * 1994-09-19 1996-04-09 Mitsubishi Chem Corp ヒトロタウイルス下痢症に対する予防および治療薬
WO1997002835A1 (en) * 1995-07-07 1997-01-30 Oravax, Inc. Intranasal vaccination against gastrointestinal disease
AU738888B2 (en) * 1997-05-29 2001-09-27 Agresearch Limited Processes for production of immunoglobulin A in milk

Also Published As

Publication number Publication date
PT1226176E (pt) 2006-06-30
AU1739001A (en) 2001-05-14
HK1048323B (zh) 2006-04-28
JP2003513106A (ja) 2003-04-08
ES2258483T3 (es) 2006-09-01
DE60025945D1 (de) 2006-04-20
WO2001032713A1 (en) 2001-05-10
ATE317400T1 (de) 2006-02-15
KR20020065497A (ko) 2002-08-13
KR100627635B1 (ko) 2006-09-25
CA2389582C (en) 2010-08-31
CA2389582A1 (en) 2001-05-10
EP1226176A1 (en) 2002-07-31
NZ518638A (en) 2003-10-31
AU779776B2 (en) 2005-02-10
EP1226176B1 (en) 2006-02-08
HK1048323A1 (en) 2003-03-28
DE60025945T2 (de) 2006-09-28
JP4668499B2 (ja) 2011-04-13
CY1105024T1 (el) 2010-03-03

Similar Documents

Publication Publication Date Title
DE60329489D1 (de) Fusionsproteine humanisierter g250-spezifischer antikörper sowie verwendungen davon
BR9809656A (pt) Composição imunopotencializante
DK0970126T3 (da) Hidtil ukendt fremgangsmåde til fremstillingen af anti-humant antigen-receptorer og anvendelser deraf
IL221708A0 (en) Polyclonal goat anti-hla class ii antibody for treatment of disease involving proliferative immune response
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
AU9399501A (en) Therapeutic antibodies
DK1448229T3 (da) Farmaceutisk sammensætning til at inducere et immunrespons hos et menneske eller et dyr
DK121683D0 (da) Fremgangsmade til fremstilling af immunoenzymatiske konjugater
DK1414858T3 (da) Kamelid-enkeltkæde-VHH-antistoffer, fremgangsmåde til fremstilling heraf i et pattedyr samt anvendelser heraf
CY1113243T1 (el) Μεθοδοι θεραπειας με χρηση αντισωματων cτlα-4
ATE476992T1 (de) Neutralisierbares epitop von hgf und an dieses bindende neutralisierender antikörper
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
CY1107390T1 (el) Εμβολιο εναντι αντιγονων απο βακτηριδια
ATE501726T1 (de) Zusammensetzung mit immunogenen mikroteilchen
WO2001081609A3 (en) Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
NO986088D0 (no) Polypeptider med evnen til Õ danne antigenbindende strukturer med spesifisi
ES2116789T3 (es) Anticuerpos monoclonales (mak) contra antigenos asociados a tumores, su preparacion y empleo.
NL7707939A (nl) Preparaat voor het opwekken van de bevalling, voor een vergemakkelijking van de bevruchting en een verhoging van de melkproduktie bij mensen en zoogdieren, vooral bij melkvee.
EP1230932A3 (de) Verwendung von Antikörpern zur Vakzinierung gegen Krebs
MX2021007047A (es) Formulaciones de anticuerpos.
DK1226176T3 (da) Produktion af brystsekret-antistoffer i landbrugsdyr
ATE397019T1 (de) Herstellung von f(ab')2 fragmenten in saügetierzelle
DE59608073D1 (de) Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid
NO20014772D0 (no) Fremgangsmåter for forhindring eller attenuering av patoangiogene tilstander
ATE237639T1 (de) Gegen die fläche von cryptosporidium-oozysten gerichteten igg1-klasse antikörper